002898 *ST赛隆药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-2.393-27.557-6.4041.795-6.846
总资产报酬率 ROA (%)-1.066-14.774-4.0871.147-4.312
投入资产回报率 ROIC (%)-1.669-19.266-4.6611.351-5.131

边际利润分析
销售毛利率 (%)11.76314.17738.25346.18653.466
营业利润率 (%)-2.264-22.045-13.4387.265-10.897
息税前利润/营业总收入 (%)-1.465-21.297-10.8059.361-8.621
净利润/营业总收入 (%)-4.262-23.490-12.5763.069-14.123

收益指标分析
经营活动净收益/利润总额(%)110.33621.90047.142-11.329123.789
价值变动净收益/利润总额(%)1.9740.308-0.20335.401-57.609
营业外收支净额/利润总额(%)10.2250.490-1.425-0.9402.968

偿债能力分析
流动比率 (X)0.8500.8400.9801.1290.858
速动比率 (X)0.5970.6440.6110.7380.642
资产负债率 (%)55.81153.83338.22534.15437.932
带息债务/全部投入资本 (%)25.01324.56626.77120.60323.488
股东权益/带息债务 (%)277.877284.890260.955367.609318.544
股东权益/负债合计 (%)77.82584.864161.607192.790163.631
利息保障倍数 (X)-1.385-24.868-4.4224.326-3.304

营运能力分析
应收账款周转天数 (天)52.76455.78665.17851.81281.619
存货周转天数 (天)63.66370.531202.345164.582171.230